Uses and challenges of antiviral polyclonal and monoclonal antibody therapies
EB Struble, JMO Rawson, T Stantchev, D Scott… - Pharmaceutics, 2023 - mdpi.com
Viral diseases represent a major public health concerns and ever-present risks for
developing into future pandemics. Antiviral antibody therapeutics, either alone or in …
developing into future pandemics. Antiviral antibody therapeutics, either alone or in …
[PDF][PDF] Marburg virus disease-a mini-review.
S Chakraborty, D Chandran, RK Mohapatra… - 2022 - academia.edu
Marburg virus disease (MVD) is a highly fatal disease caused by the Marburg virus (MARV)
which belongs to the family Filoviridae. The disease has been recently reported from Ghana …
which belongs to the family Filoviridae. The disease has been recently reported from Ghana …
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model
Since SARS-CoV-2 emerged in late 2019, it spread from China to the rest of the world. An
initial concern was the potential for vaccine-or antibody-dependent enhancement (ADE) of …
initial concern was the potential for vaccine-or antibody-dependent enhancement (ADE) of …
[HTML][HTML] SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity
EJ Martinez, WC Chang, WH Chen, A Hajduczki… - iScience, 2024 - cell.com
The rapid emergence of SARS-CoV-2 variants of concern (VoC) and the threat of future
zoonotic sarbecovirus spillover emphasizes the need for broadly protective next-generation …
zoonotic sarbecovirus spillover emphasizes the need for broadly protective next-generation …
Comparison of neutralization potency across passive immunotherapy approaches as potential treatments for emerging infectious diseases
The use of passive immunotherapy, either as plasma or purified antibodies, has been
recommended to treat the emerging infectious diseases (EIDs) in the absence of alternative …
recommended to treat the emerging infectious diseases (EIDs) in the absence of alternative …
No evidence for enhanced disease with polyclonal SARS-CoV-2 antibody in the ferret model
Since SARS-CoV-2 emerged in late 2019, it spread from China to the rest of the world. An
initial concern was the potential for vaccine-or antibody-enhanced disease (AED) as had …
initial concern was the potential for vaccine-or antibody-enhanced disease (AED) as had …
A Drug-Virus Prediction Model Based on an Ensemble Classifier with Feature Optimization: A Case Study with COVID-19
Effective therapeutics are still unavailable for the contagious COVID-19, which originated in
Wuhan in December 2019. It is induced by the newly emerged severe acute respiratory …
Wuhan in December 2019. It is induced by the newly emerged severe acute respiratory …
Computational Discovery of Potential Drug Candidates from Phytochemicals of Withania somnifera and Saraca asoca Targeting Ebola and Marburg Viruses Infection
Ebola and Marburg viruses are extremely lethal and cause hemorrhagic fever, with deaths
from cases exceeding 90%. Currently, just a few licensed drugs for these diseases. This …
from cases exceeding 90%. Currently, just a few licensed drugs for these diseases. This …